Ekman A - Search Results

1

Inverse agonism at dopamine D2 receptors. Haloperidol-induced prolactin release from GH4C1 cells transfected with the human D2 receptor is antagonized by R(-)-n-propylnorapomorphine, raclopride, and phenoxybenzamine.

Nilsson CL, Ekman A, Hellstrand M, Eriksson E. Nilsson CL, et al. Among authors: ekman a. Neuropsychopharmacology. 1996 Jul;15(1):53-61. doi: 10.1016/0893-133X(95)00156-8. Neuropsychopharmacology. 1996. PMID: 8797192

2

Central administration of dopamine D3 receptor antisense to rat: effects on locomotion, dopamine release and [3H]spiperone binding.

Ekman A, Nissbrandt H, Heilig M, Dijkstra D, Eriksson E. Ekman A, et al. Naunyn Schmiedebergs Arch Pharmacol. 1998 Sep;358(3):342-50. doi: 10.1007/pl00005263. Naunyn Schmiedebergs Arch Pharmacol. 1998. PMID: 9774222

3

Orally active central dopamine and serotonin receptor ligands: 5-, 6-, 7-, and 8-[[trifluoromethyl)sulfonyl]oxy]-2-(di-n-propylamino)tetralins and the formation of active metabolites in vivo.

Sonesson C, Boije M, Svensson K, Ekman A, Carlsson A, Romero AG, Martin IJ, Duncan JN, King LJ, Wikström H. Sonesson C, et al. Among authors: ekman a. J Med Chem. 1993 Oct 29;36(22):3409-16. doi: 10.1021/jm00074a022. J Med Chem. 1993. PMID: 8230131

4

A high dose of EEDQ reduces pituitary dopamine D2 receptor density and the prolactin suppressive potency of agonists.

Ekman A, Eriksson E. Ekman A, et al. Eur J Pharmacol. 1993 Oct 26;243(3):295-9. doi: 10.1016/0014-2999(93)90189-o. Eur J Pharmacol. 1993. PMID: 7903944

5

Dopamine D3 receptor antisense influences dopamine synthesis in rat brain.

Nissbrandt H, Ekman A, Eriksson E, Heilig M. Nissbrandt H, et al. Among authors: ekman a. Neuroreport. 1995 Feb 15;6(3):573-6. doi: 10.1097/00001756-199502000-00041. Neuroreport. 1995. PMID: 7766866

6

The effects of 1-methyl-4-phenylpyridinium ion (MPP+) on the efflux and metabolism of endogenous dopamine in rat striatal slices.

Snape BM, Pileblad E, Ekman A, Magnusson T, Carlsson A, Engel J. Snape BM, et al. Among authors: ekman a. J Pharm Pharmacol. 1988 Sep;40(9):620-6. doi: 10.1111/j.2042-7158.1988.tb05321.x. J Pharm Pharmacol. 1988. PMID: 2907028

7

Resolved 6,7,8,9-tetrahydro-N,N-dimethyl-3H-benz[e]indol-8-amine: central dopamine and serotonin receptor stimulating properties.

Wikström H, Andersson B, Svensson A, Humber LG, Asselin AA, Svensson K, Ekman A, Carlsson A, Nilsson I, Chidester C. Wikström H, et al. Among authors: ekman a. J Med Chem. 1989 Oct;32(10):2273-6. doi: 10.1021/jm00130a008. J Med Chem. 1989. PMID: 2571729

8

Pituitary and brain D2 receptor density measured in vitro and in vivo in EEDQ treated male rats.

Ekman A, Eriksson E. Ekman A, et al. Life Sci. 1991;48(4):321-31. doi: 10.1016/0024-3205(91)90552-m. Life Sci. 1991. PMID: 1824955

9

Effects of the partial dopamine receptor agonists SDZ 208-911, SDZ 208-912 and terguride on central monoamine receptors. A behavioral, biochemical and electrophysiological study.

Svensson K, Ekman A, Piercey MF, Hoffmann WE, Lum JT, Carlsson A. Svensson K, et al. Among authors: ekman a. Naunyn Schmiedebergs Arch Pharmacol. 1991 Sep;344(3):263-74. doi: 10.1007/BF00182999. Naunyn Schmiedebergs Arch Pharmacol. 1991. PMID: 1683686

10

Effects of the two partial D2 agonists (+)- and (-)-3-PPP on prolactin release in EEDQ treated male rats.

Ekman A, Quiding M, Eriksson E. Ekman A, et al. Life Sci. 1991;48(4):311-20. doi: 10.1016/0024-3205(91)90551-l. Life Sci. 1991. PMID: 1671291

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results